5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 30.76▼ | 30.83▼ | 30.87▼ | 30.72▼ | 29.28▲ |
MA10 | 30.80▼ | 30.95▼ | 31.13▼ | 29.97▲ | 31.90▼ |
MA20 | 30.85▼ | 31.15▼ | 31.08▼ | 29.36▲ | 31.39▼ |
MA50 | 30.90▼ | 30.92▼ | 30.48▲ | 32.45▼ | 33.78▼ |
MA100 | 31.19▼ | 30.35▲ | 29.36▲ | 31.57▼ | 36.79▼ |
MA200 | 31.10▼ | 29.32▲ | 30.59▲ | 33.91▼ | 50.93▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.089▼ | -0.099▼ | 0.411▲ | -0.151▼ |
RSI | 36.218▼ | 42.849▼ | 46.998▼ | 50.446▲ | 45.279▼ |
STOCH | 30.405 | 20.446 | 20.685 | 86.839▲ | 26.676 |
WILL %R | -83.333▼ | -93.204▼ | -93.204▼ | -33.046 | -61.532 |
CCI | -193.607▼ | -82.824 | -101.758▼ | 109.592▲ | -30.311 |
Thursday, May 01, 2025 11:09 AM
Baxter Chair and interim CEO Brent Shafer said some tariff mitigation activities are underway while others are being developed.
|
Thursday, May 01, 2025 08:36 AM
Baxter raised its 2025 outlook after strong Q1 results, citing robust growth in infusion therapies and advanced surgery.
|
Thursday, May 01, 2025 08:35 AM
Baxter International (NYSE:BAX) stock rose after the company reported its first quarter earnings above estimates and raised full year adjusted profit guidance, backed by rising U.S. sales. The ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 32.15 | 32.59 | 30.52 | 30.67 | 7,085,565 |
30/04/25 | 31.11 | 31.375 | 30.63 | 31.17 | 5,553,200 |
29/04/25 | 30.47 | 31.345 | 30.35 | 31.00 | 2,962,049 |
28/04/25 | 30.31 | 30.82 | 30.09 | 30.53 | 3,970,800 |
25/04/25 | 30.22 | 30.43 | 29.96 | 30.22 | 3,466,652 |
24/04/25 | 29.72 | 30.48 | 29.49 | 30.41 | 3,601,300 |
23/04/25 | 29.24 | 30.30 | 29.17 | 29.60 | 4,590,187 |
22/04/25 | 28.89 | 29.13 | 28.50 | 28.62 | 4,604,349 |
21/04/25 | 28.75 | 28.81 | 28.27 | 28.54 | 4,066,742 |
17/04/25 | 27.97 | 29.10 | 27.92 | 28.89 | 5,523,452 |
|
|
||||
|
|
||||
|
|